Publication: Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci
| dc.contributor.author | Chen, Hongjie | |
| dc.contributor.author | Fan, Shaoqi | |
| dc.contributor.author | Stone, Jennifer | |
| dc.contributor.author | Thompson, Deborah J | |
| dc.contributor.author | Douglas, Julie | |
| dc.contributor.author | Li, Shuai | |
| dc.contributor.author | Scott, Christopher | |
| dc.contributor.author | Bolla, Manjeet K | |
| dc.contributor.author | Wang, Qin | |
| dc.contributor.author | Dennis, Joe | |
| dc.contributor.author | Michailidou, Kyriaki | |
| dc.contributor.author | Li, Christopher | |
| dc.contributor.author | Peters, Ulrike | |
| dc.contributor.author | Hopper, John L | |
| dc.contributor.author | Southey, Melissa C | |
| dc.contributor.author | Nguyen-Dumont, Tu | |
| dc.contributor.author | Nguyen, Tuong L | |
| dc.contributor.author | Fasching, Peter A | |
| dc.contributor.author | Behrens, Annika | |
| dc.contributor.author | Cadby, Gemma | |
| dc.contributor.author | Murphy, Rachel A | |
| dc.contributor.author | Aronson, Kristan | |
| dc.contributor.author | Howell, Anthony | |
| dc.contributor.author | Astley, Susan | |
| dc.contributor.author | Couch, Fergus | |
| dc.contributor.author | Olson, Janet | |
| dc.contributor.author | Milne, Roger L | |
| dc.contributor.author | Giles, Graham G | |
| dc.contributor.author | Haiman, Christopher A | |
| dc.contributor.author | Maskarinec, Gertraud | |
| dc.contributor.author | Winham, Stacey | |
| dc.contributor.author | John, Esther M | |
| dc.contributor.author | Kurian, Allison | |
| dc.contributor.author | Eliassen, Heather | |
| dc.contributor.author | Andrulis, Irene | |
| dc.contributor.author | Evans, D Gareth | |
| dc.contributor.author | Newman, William G | |
| dc.contributor.author | Hall, Per | |
| dc.contributor.author | Czene, Kamila | |
| dc.contributor.author | Swerdlow, Anthony | |
| dc.contributor.author | Jones, Michael | |
| dc.contributor.author | Pollan-Santamaria, Marina | |
| dc.contributor.author | Fernandez-Navarro, Pablo L | |
| dc.contributor.author | McConnell, Daniel S | |
| dc.contributor.author | Kristensen, Vessela N | |
| dc.contributor.author | Rothstein, Joseph H | |
| dc.contributor.author | Wang, Pei | |
| dc.contributor.author | Habel, Laurel A | |
| dc.contributor.author | Sieh, Weiva | |
| dc.contributor.author | Dunning, Alison M | |
| dc.contributor.author | Pharoah, Paul D P | |
| dc.contributor.author | Easton, Douglas F | |
| dc.contributor.author | Gierach, Gretchen L | |
| dc.contributor.author | Tamimi, Rulla M | |
| dc.contributor.author | Vachon, Celine M | |
| dc.contributor.author | Lindström, Sara | |
| dc.contributor.funder | Unión Europea. Comisión Europea. H2020 | es_ES |
| dc.contributor.funder | Canadian Institutes of Health Research | es_ES |
| dc.contributor.funder | Quebec Breast Cancer Foundation | es_ES |
| dc.contributor.funder | Government of Quebec (Canadá) | es_ES |
| dc.contributor.funder | National Institutes of Health (Estados Unidos) | es_ES |
| dc.contributor.funder | Unión Europea. Comisión Europea. 7 Programa Marco | es_ES |
| dc.contributor.funder | Cancer Research UK (Reino Unido) | es_ES |
| dc.contributor.funder | Susan G. Komen Breast Cancer Foundation | es_ES |
| dc.contributor.funder | Ovarian Cancer Research Foundation (Astrualia) | es_ES |
| dc.contributor.funder | Australian Breast Cancer Family Study | es_ES |
| dc.contributor.funder | NIH - National Cancer Institute (NCI) (Estados Unidos) | es_ES |
| dc.contributor.funder | National Health and Medical Research Council (Australia) | es_ES |
| dc.contributor.funder | New South Wales Cancer Council (Reino Unido) | es_ES |
| dc.contributor.funder | Victorian Cancer Agency | es_ES |
| dc.contributor.funder | National Breast Cancer Foundation (Australia) | es_ES |
| dc.contributor.funder | Cancer Australia | es_ES |
| dc.contributor.funder | Universitätsklinikum Erlangen (Alemania) | es_ES |
| dc.contributor.funder | Consorcio Gallego de Cáncer de Mama (BREOGAN) | es_ES |
| dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | es_ES |
| dc.contributor.funder | Galicia Sur Biomedical Foundation | es_ES |
| dc.contributor.funder | Xunta de Galicia (España) | es_ES |
| dc.contributor.funder | Ministerio de Sanidad, Servicios Sociales e Igualdad (España) | es_ES |
| dc.contributor.funder | Ministerio de Economía y Competitividad (España) | es_ES |
| dc.contributor.funder | Canadian Cancer Society | es_ES |
| dc.contributor.funder | NIHR - Manchester Biomedical Research Centre (Reino Unido) | es_ES |
| dc.contributor.funder | Cancer Council New South Wales (Australia) | es_ES |
| dc.contributor.funder | Cancer Council Victoria (Australia) | es_ES |
| dc.contributor.funder | Cancer Council Tasmania (Australia) | es_ES |
| dc.contributor.funder | Cancer Council South (Australia) | es_ES |
| dc.contributor.funder | Cancer Council Western Australia (Australia) | es_ES |
| dc.contributor.funder | United States Army Medical Research and Development Command | es_ES |
| dc.contributor.funder | Cancer Council Queensland (Australia) | es_ES |
| dc.contributor.funder | NIH - NCI-Specialized Programs of Research Excellence (SPORE) in Breast Cancer (Estados Unidos) | es_ES |
| dc.contributor.funder | Victorian Health Promotion Foundation | es_ES |
| dc.contributor.funder | The Research Council of Norway (Noruega) | es_ES |
| dc.contributor.funder | Southern and Eastern Norway Regional Health Authority | es_ES |
| dc.contributor.funder | Norwegian Cancer Society | es_ES |
| dc.contributor.funder | Agency for Science, Technology and Research (Singapur) | es_ES |
| dc.contributor.funder | Institute of Cancer Research (Reino Unido) | es_ES |
| dc.contributor.funder | NIHR - Manchester Biomedical Research Centre (Reino Unido) | es_ES |
| dc.date.accessioned | 2022-08-05T11:01:17Z | |
| dc.date.available | 2022-08-05T11:01:17Z | |
| dc.date.issued | 2022-04-12 | |
| dc.description.abstract | Background: Mammographic density (MD) phenotypes, including percent density (PMD), area of dense tissue (DA), and area of non-dense tissue (NDA), are associated with breast cancer risk. Twin studies suggest that MD phenotypes are highly heritable. However, only a small proportion of their variance is explained by identified genetic variants. Methods: We conducted a genome-wide association study, as well as a transcriptome-wide association study (TWAS), of age- and BMI-adjusted DA, NDA, and PMD in up to 27,900 European-ancestry women from the MODE/BCAC consortia. Results: We identified 28 genome-wide significant loci for MD phenotypes, including nine novel signals (5q11.2, 5q14.1, 5q31.1, 5q33.3, 5q35.1, 7p11.2, 8q24.13, 12p11.2, 16q12.2). Further, 45% of all known breast cancer SNPs were associated with at least one MD phenotype at p < 0.05. TWAS further identified two novel genes (SHOX2 and CRISPLD2) whose genetically predicted expression was significantly associated with MD phenotypes. Conclusions: Our findings provided novel insight into the genetic background of MD phenotypes, and further demonstrated their shared genetic basis with breast cancer. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | This work was supported by CA244670 and CA194393. European Union's Horizon 2020 Research and Innovation Programme (grant numbers 634935 and 633784 for BRIDGES and B-CAST respectively), and the PERSPECTIVE I&I project, funded by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, the Ministère de l’Économie et de l'Innovation du Québec through Genome Québec, the Quebec Breast Cancer Foundation. The EU Horizon 2020 Research and Innovation Programme funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report. Additional funding for BCAC is provided via the Confluence project which is funded with intramural funds from the National Cancer Institute Intramural Research Program, National Institutes of Health. Genotyping of the OncoArray was funded by the NIH Grant U19 CA148065, and Cancer UK Grant C1287/A16563 and the PERSPECTIVE project supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research (grant GPH-129344) and, the Ministère de l’Économie, Science et Innovation du Québec through Genome Québec and the PSRSIIRI-701 grant, and the Quebec Breast Cancer Foundation. Funding for iCOGS came from: the European Community's Seventh Framework Programme under grant agreement n° 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565), the National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 - the GAME-ON initiative), the Department of Defence (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, and Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund. The Australian Breast Cancer Family Study (ABCFS) was supported by grant UM1 CA164920 from the National Cancer Institute (USA). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. J.L.H. is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow. M.C.S. is a NHMRC Senior Research Fellow. The Australian Mammographic Density Twins and Sisters Study (AMDTSS) was supported by the National Breast Cancer Foundation, Cancer Australia, the National Health and Medical Research Council of Australia, and facilitated by Twins Research Australia. The work of the BBCC was partly funded by ELAN-Fond of the University Hospital of Erlangen. The BCEES was funded by the National Health and Medical Research Council, Australia and the Cancer Council Western Australia and acknowledges funding from the National Breast Cancer Foundation (JS). The BREast Oncology GAlician Network (BREOGAN) is funded by Acción Estratégica de Salud del Instituto de Salud Carlos III FIS PI12/02125/Cofinanciado FEDER; Acción Estratégica de Salud del Instituto de Salud Carlos III FIS Intrasalud (PI13/01136); Programa Grupos Emergentes, Cancer Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur. Xerencia de Xestion Integrada de Vigo-SERGAS, Instituto de Salud Carlos III, Spain; Grant 10CSA012E, Consellería de Industria Programa Sectorial de Investigación Aplicada, PEME I + D e I + D Suma del Plan Gallego de Investigación, Desarrollo e Innovación Tecnológica de la Consellería de Industria de la Xunta de Galicia, Spain; Grant EC11-192. Fomento de la Investigación Clínica Independiente, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain; and Grant FEDER-Innterconecta. Ministerio de Economia y Competitividad, Xunta de Galicia, Spain. CBCS is funded by the Canadian Cancer Society (grant # 313404) and the Canadian Institutes of Health Research. FHRISK and PROCAS are funded from NIHR grant PGfAR 0707-10031. DGE, AH and WGN are supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007). kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], Cancer Council Victoria, Queensland Cancer Fund, Cancer Council New South Wales, Cancer Council South Australia, The Cancer Foundation of Western Australia, Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; 400413, 400281, 199600). G.C.T. and P.W. are supported by the NHMRC. RB was a Cancer Institute NSW Clinical Research Fellow. LAMBDA The MCBCS was supported by the NIH grants R35CA253187, R01CA192393, R01CA116167, R01CA176785 a NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [P50CA116201], and the Breast Cancer Research Foundation. Melbourne Collaborative Cohort Study (MCCS) cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further augmented by Australian National Health and Medical Research Council grants 209057, 396414 and 1074383 and by infrastructure provided by Cancer Council Victoria. Cases and their vital status were ascertained through the Victorian Cancer Registry and the Australian Institute of Health and Welfare, including the National Death Index and the Australian Cancer Database. The MEC was supported by NIH grants CA63464, CA54281, CA098758, CA132839 and CA164973. The MMHS study was supported by NIH grants CA97396, CA128931, CA116201, CA140286 and CA177150. The NBCS has received funding from the K.G. Jebsen Centre for Breast Cancer Research; the Research Council of Norway grant 193387/V50 (to A-L Børresen-Dale and V.N. Kristensen) and grant 193387/H10 (to A-L Børresen-Dale and V.N. Kristensen), South Eastern Norway Health Authority (grant 39346 to A-L Børresen-Dale) and the Norwegian Cancer Society (to A-L Børresen-Dale and V.N. Kristensen). The Northern California Breast Cancer Family Registry (NC-BCFR) and Ontario Familial Breast Cancer Registry (OFBCR) were supported by grant U01CA164920 from the USA National Cancer Institute of the National Institutes of Health. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the USA Government or the BCFR. The NHS was supported by NIH grants P01 CA87969, UM1 CA186107, and U19 CA148065. The NHS2 was supported by NIH grants UM1 CA176726 and U19 CA148065. The PBCS was funded by the Intramural Research Program of the National Cancer Institute, Department of Health and Human Services, USA. The SASBAC study was supported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. UKBGS is funded by Breast Cancer Now and the Institute of Cancer Research (ICR), London. ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. The replication of GWAS and TWAS results is supported by NIH grants R01CA166827, R01CA168893, and R01CA237541. | es_ES |
| dc.format.number | 1 | es_ES |
| dc.format.page | 27 | es_ES |
| dc.format.volume | 24 | es_ES |
| dc.identifier.citation | Breast Cancer Res. 2022 Apr 12;24(1):27. | es_ES |
| dc.identifier.doi | 10.1186/s13058-022-01524-0 | es_ES |
| dc.identifier.e-issn | 1465-542X | es_ES |
| dc.identifier.journal | Breast Cancer Research : BCR | es_ES |
| dc.identifier.pubmedID | 35414113 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/14868 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | BioMed Central (BMC) | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI12/02125 | es_ES |
| dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/PI13/01136 | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/634935/EU | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/633784/EU | es_ES |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/223175/EU | es_ES |
| dc.relation.publisherversion | https://doi.org/10.1186/s13058-022-01524-0 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Breast cancer | es_ES |
| dc.subject | Genome-wide association study (GWAS) | es_ES |
| dc.subject | Mammographic density | es_ES |
| dc.subject | Transcriptome-wide association study (TWAS) | es_ES |
| dc.subject.mesh | Breast Density | es_ES |
| dc.subject.mesh | Breast Neoplasms | es_ES |
| dc.subject.mesh | Female | es_ES |
| dc.subject.mesh | Genetic Predisposition to Disease | es_ES |
| dc.subject.mesh | Genome-Wide Association Study | es_ES |
| dc.subject.mesh | Humans | es_ES |
| dc.subject.mesh | Phenotype | es_ES |
| dc.subject.mesh | Polymorphism, Single Nucleotide | es_ES |
| dc.subject.mesh | Transcriptome | es_ES |
| dc.title | Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci | es_ES |
| dc.type | journal article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | cb3b77d8-c78c-4238-9b9d-c1171ff3ab51 | |
| relation.isAuthorOfPublication | 204c29c1-c32f-483d-9ed7-1b12ec018754 | |
| relation.isAuthorOfPublication.latestForDiscovery | cb3b77d8-c78c-4238-9b9d-c1171ff3ab51 |
Files
Original bundle
1 - 3 of 3
Loading...
- Name:
- GenomeWideAndTranscriptome_2022.pdf
- Size:
- 1.63 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo principal
Loading...
- Name:
- GenomeWideAndTranscriptomeAdditionalFile1_2022.pdf
- Size:
- 9.63 MB
- Format:
- Adobe Portable Document Format
- Description:
- Supplementary Information
Loading...
- Name:
- GenomeWideAndTranscriptomeAdditionalFile2_2022.xlsx
- Size:
- 3.42 MB
- Format:
- Microsoft Excel XML
- Description:
- Supplementary Information


